Skip to main content
PMC home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1983 Nov;113(2):143–155.

Biologic determinants of dystrophic calcification and osteocalcin deposition in glutaraldehyde-preserved porcine aortic valve leaflets implanted subcutaneously in rats.

R J Levy, F J Schoen, J T Levy, A C Nelson, S L Howard, L J Oshry
PMCID: PMC1916380  PMID: 6605687

Abstract

Bioprosthetic cardiac valve calcification is a frequent complication after long-term valve replacement. In this study the authors sought to examine the biologic determinants of this type of dystrophic calcification using subcutaneous implants of glutaraldehyde-preserved porcine aortic valve leaflets (GPVs) in rats. GPVs and clinical valvular bioprostheses were prepared identically. Retrieved implants were examined for calcification and the deposition of osteocalcin (OC), a vitamin K-dependent, bone-derived protein, that is found in other dystrophic and ectopic calcifications. GPVs implanted in 3-week-old rats calcified progressively (GPV Ca2+, 122.9 +/- 6.0 micrograms/mg) after 21 days, with mineral deposition occurring in a morphologic pattern comparable to that noted in clinical retrievals. Calcified GPVs accumulated osteocalcin (OC, 183.4 +/- 19.4 ng/mg); Nonpreserved porcine aortic leaflet implants did not calcify (Ca2+ + 5.6 +/- 1.0 micrograms/mg). Millipore diffusion chamber (0.45-mu pore size enclosed GPV implants accumulated calcium and adsorbed osteocalcin despite the absence of attached host cells. GPVs implanted for 21 days in 8-month-old rats calcified less (GPV Ca2+, 22.4 +/- 5.0 micrograms/mg) than did GPVs implanted in 3-week-old rats (see above). High-dose warfarin therapy (80 mg/kg) did not alter GPV calcification (GPV Ca2+, 39.6 +/- 2.9 micrograms/mg) in 72-hour subcutaneous implants in 3-week-old male rats, compared with control rats (GPV Ca2+, 40.8 +/- 4.8 micrograms/mg).

Full text

PDF
143

Images in this article

147Figure 3
on p.147
145Figure 1
on p.145
146Figure 2
on p.146
148Figure 4
on p.148
149Figure 6
on p.149
150Figure 7
on p.150

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Angell W. W., Angell J. D., Kosek J. C. Twelve-year experience with glutaraldehyde-preserved porcine xenografts. J Thorac Cardiovasc Surg. 1982 Apr;83(4):493–502. [PubMed] [Google Scholar]
  2. Barnhart G. R., Jones M., Ishihara T., Rose D. M., Chavez A. M., Ferrans V. J. Degeneration and calcification of bioprosthetic cardiac valves. Bioprosthetic tricuspid valve implantation in sheep. Am J Pathol. 1982 Jan;106(1):136–139. [PMC free article] [PubMed] [Google Scholar]
  3. Borkon A. M., McIntosh C. L., Von Rueden T. J., Morrow A. G. Mitral valve replacement with the Hancock bioprosthesis: five- to ten-year follow-up. Ann Thorac Surg. 1981 Aug;32(2):127–137. doi: 10.1016/s0003-4975(10)61019-3. [DOI] [PubMed] [Google Scholar]
  4. Bortolotti U., Milano A., Mazzucco A., Valfre C., Russo R., Valente M., Schivazappa L., Thiene G., Gallucci V. Pregnancy in patients with a porcine valve bioprosthesis. Am J Cardiol. 1982 Nov;50(5):1051–1054. doi: 10.1016/0002-9149(82)90416-7. [DOI] [PubMed] [Google Scholar]
  5. Bowes J. H., Cater C. W. The interaction of aldehydes with collagen. Biochim Biophys Acta. 1968 Oct 21;168(2):341–352. doi: 10.1016/0005-2795(68)90156-6. [DOI] [PubMed] [Google Scholar]
  6. Carpentier A., Deloche A., Relland J., Fabiani J. N., Forman J., Camilleri J. P., Soyer R., Dubost C. Six-year follow-up of glutaraldehyde-preserved heterografts. With particular reference to the treatment of congenital valve malformations. J Thorac Cardiovasc Surg. 1974 Nov;68(5):771–782. [PubMed] [Google Scholar]
  7. Carpentier A., Lemaigre G., Robert L., Carpentier S., Dubost C. Biological factors affecting long-term results of valvular heterografts. J Thorac Cardiovasc Surg. 1969 Oct;58(4):467–483. [PubMed] [Google Scholar]
  8. Cohn L. H., Mudge G. H., Pratter F., Collins J. J., Jr Five to eight-year follow-up of patients undergoing porcine heart-valve replacement. N Engl J Med. 1981 Jan 29;304(5):258–262. doi: 10.1056/NEJM198101293040503. [DOI] [PubMed] [Google Scholar]
  9. DeLuca H. F., Schnoes H. K. Metabolism and mechanism of action of vitamin D. Annu Rev Biochem. 1976;45:631–666. doi: 10.1146/annurev.bi.45.070176.003215. [DOI] [PubMed] [Google Scholar]
  10. DeVore D. T. Collagen xenografts for bone replacement: the effects of aldehyde-induced cross-linking on degradation rate. Oral Surg Oral Med Oral Pathol. 1977 May;43(5):677–686. doi: 10.1016/0030-4220(77)90050-0. [DOI] [PubMed] [Google Scholar]
  11. Dunn J. M. Porcine valve durability in children. Ann Thorac Surg. 1981 Oct;32(4):357–368. doi: 10.1016/s0003-4975(10)61757-2. [DOI] [PubMed] [Google Scholar]
  12. Eyre D. R., Oguchi H. The hydroxypyridinium crosslinks of skeletal collagens: their measurement, properties and a proposed pathway of formation. Biochem Biophys Res Commun. 1980 Jan 29;92(2):403–410. doi: 10.1016/0006-291x(80)90347-2. [DOI] [PubMed] [Google Scholar]
  13. Ferrans V. J., Boyce S. W., Billingham M. E., Jones M., Ishihara T., Roberts W. C. Calcific deposits in porcine bioprostheses: structure and pathogenesis. Am J Cardiol. 1980 Nov;46(5):721–734. doi: 10.1016/0002-9149(80)90421-x. [DOI] [PubMed] [Google Scholar]
  14. Ferrans V. J., Spray T. L., Billingham M. E., Roberts W. C. Structural changes in glutaraldehyde-treated porcine heterografts used as substitute cardiac valves. Transmission and scanning electron microscopic observations in 12 patients. Am J Cardiol. 1978 Jun;41(7):1159–1184. doi: 10.1016/0002-9149(78)90873-1. [DOI] [PubMed] [Google Scholar]
  15. Fishbein M. C., Gissen S. A., Collins J. J., Jr, Barsamian E. M., Cohn L. H. Pathologic findings after cardiac valve replacement with glutaraldehyde-fixed porcine valves. Am J Cardiol. 1977 Sep;40(3):331–337. doi: 10.1016/0002-9149(77)90154-0. [DOI] [PubMed] [Google Scholar]
  16. Fishbein M. C., Levy R. J., Ferrans V. J., Dearden L. C., Nashef A., Goodman A. P., Carpentier A. Calcifications of cardiac valve bioprostheses. Biochemical, histologic, and ultrastructural observations in a subcutaneous implantation model system. J Thorac Cardiovasc Surg. 1982 Apr;83(4):602–609. [PubMed] [Google Scholar]
  17. Gallop P. M., Paz M. A. Posttranslational protein modifications, with special attention to collagen and elastin. Physiol Rev. 1975 Jul;55(3):418–487. doi: 10.1152/physrev.1975.55.3.418. [DOI] [PubMed] [Google Scholar]
  18. Harasaki H., Gerrity R., Kiraly R., Jacobs G., Nosé Y. Calcification in blood pumps. Trans Am Soc Artif Intern Organs. 1979;25:305–310. doi: 10.1097/00002480-197902500-00055. [DOI] [PubMed] [Google Scholar]
  19. Hauschka P. V., Lian J. B., Gallop P. M. Direct identification of the calcium-binding amino acid, gamma-carboxyglutamate, in mineralized tissue. Proc Natl Acad Sci U S A. 1975 Oct;72(10):3925–3929. doi: 10.1073/pnas.72.10.3925. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Hauschka P. V. Quantitative determination of gamma-carboxyglutamic acid in proteins. Anal Biochem. 1977 May 15;80(1):212–223. doi: 10.1016/0003-2697(77)90640-6. [DOI] [PubMed] [Google Scholar]
  21. Hauschka P. V., Reid M. L. Timed appearance of a calcium-binding protein containing gamma-carboxyglutamic acid in developing chick bone. Dev Biol. 1978 Aug;65(2):426–434. doi: 10.1016/0012-1606(78)90038-6. [DOI] [PubMed] [Google Scholar]
  22. Hauschka P. V., Reid M. L. Vitamin D dependence of a calcium-binding protein containing gamma-carboxyglutamic acid in chicken bone. J Biol Chem. 1978 Dec 25;253(24):9063–9068. [PubMed] [Google Scholar]
  23. Ishihara T., Ferrans V. J., Boyce S. W., Jones M., Roberts W. C. Structure and classification of cuspal tears and perforations in porcine bioprosthetic cardiac valves implanted in patients. Am J Cardiol. 1981 Oct;48(4):665–678. doi: 10.1016/0002-9149(81)90145-4. [DOI] [PubMed] [Google Scholar]
  24. Korn A. H., Feairheller S. H., Filachione E. M. Glutaraldehyde: nature of the reagent. J Mol Biol. 1972 Apr 14;65(3):525–529. doi: 10.1016/0022-2836(72)90206-9. [DOI] [PubMed] [Google Scholar]
  25. Kramsch D. M., Aspen A. J., Rozler L. J. Atherosclerosis: Prevention by agents not affecting abnormal levels of blood lipids. Science. 1981 Sep 25;213(4515):1511–1512. doi: 10.1126/science.6792706. [DOI] [PubMed] [Google Scholar]
  26. Kutsche L. M., Oyer P., Shumway N., Baum D. An important complication of Hancock mitral valve replacement in children. Circulation. 1979 Aug;60(2 Pt 2):98–103. doi: 10.1161/01.cir.60.2.98. [DOI] [PubMed] [Google Scholar]
  27. Lakier J. B., Khaja F., Magilligan D. J., Jr, Goldstein S. Porcine xenograft valves. Long-term (60-89-month) follow-up. Circulation. 1980 Aug;62(2):313–318. doi: 10.1161/01.cir.62.2.313. [DOI] [PubMed] [Google Scholar]
  28. Lentz D. J., Pollock E. M., Olsen D. B., Andrews E. J. Prevention of intrinsic calcification in porcine and bovine xenograft materials. Trans Am Soc Artif Intern Organs. 1982;28:494–497. [PubMed] [Google Scholar]
  29. Levy R. J., Gundberg C., Scheinman R. The identification of the vitamin K-dependent bone protein osteocalcin as one of the gamma-carboxyglutamic acid containing proteins present in calcified atherosclerotic plaque and mineralized heart valves. Atherosclerosis. 1983 Jan;46(1):49–56. doi: 10.1016/0021-9150(83)90163-6. [DOI] [PubMed] [Google Scholar]
  30. Levy R. J., Lian J. B., Gallop P. Atherocalcin, a gamma-carboxyglutamic acid containing protein from atherosclerotic plaque. Biochem Biophys Res Commun. 1979 Nov 14;91(1):41–49. doi: 10.1016/0006-291x(79)90580-1. [DOI] [PubMed] [Google Scholar]
  31. Levy R. J., Zenker J. A., Lian J. B. Vitamin K-dependent calcium binding proteins in aortic valve calcification. J Clin Invest. 1980 Feb;65(2):563–566. doi: 10.1172/JCI109700. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Lian J. B., Glimcher M. J., Roufosse A. H., Hauschka P. V., Gallop P. M., Cohen-Solal L., Reit B. Alterations of the gamma-carboxyglutamic acid and osteocalcin concentrations in vitamin D-deficient chick bone. J Biol Chem. 1982 May 10;257(9):4999–5003. [PubMed] [Google Scholar]
  33. Lian J. B., Skinner M., Glimcher M. J., Gallop P. The presence of gamma-carboxyglutamic acid in the proteins associated with ectopic calcification. Biochem Biophys Res Commun. 1976 Nov 22;73(2):349–355. doi: 10.1016/0006-291x(76)90714-2. [DOI] [PubMed] [Google Scholar]
  34. Oyer P. E., Miller D. C., Stinson E. B., Reitz B. A., Moreno-Cabral R. J., Shumway N. E. Clinical durability of the Hancock porcine bioprosthetic valve. J Thorac Cardiovasc Surg. 1980 Dec;80(6):824–833. [PubMed] [Google Scholar]
  35. Paz M. A., Keith D. A., Traverso H. P., Gallop P. M. Isolation, purification, and cross-linking profiles of elastin from lung and aorta. Biochemistry. 1976 Nov 2;15(22):4912–4918. doi: 10.1021/bi00667a025. [DOI] [PubMed] [Google Scholar]
  36. Pierce W. S., Donachy J. H., Rosenberg G., Baier R. E. Calcification inside artificial hearts: inhibition by warfarin-sodium. Science. 1980 May 9;208(4444):601–603. doi: 10.1126/science.7367883. [DOI] [PubMed] [Google Scholar]
  37. Price P. A., Baukol S. A. 1,25-Dihydroxyvitamin D3 increases synthesis of the vitamin K-dependent bone protein by osteosarcoma cells. J Biol Chem. 1980 Dec 25;255(24):11660–11663. [PubMed] [Google Scholar]
  38. Price P. A., Baukol S. A. 1,25-dihydroxyvitamin D3 increases serum levels of the vitamin K-dependent bone protein. Biochem Biophys Res Commun. 1981 Apr 15;99(3):928–935. doi: 10.1016/0006-291x(81)91252-3. [DOI] [PubMed] [Google Scholar]
  39. Price P. A., Williamson M. K., Haba T., Dell R. B., Jee W. S. Excessive mineralization with growth plate closure in rats on chronic warfarin treatment. Proc Natl Acad Sci U S A. 1982 Dec;79(24):7734–7738. doi: 10.1073/pnas.79.24.7734. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Reddi A. H., Huggins C. B. Cyclic electrochemical inactivation and restoration of competence of bone matrix to transform fibroblasts. Proc Natl Acad Sci U S A. 1974 May;71(5):1648–1652. doi: 10.1073/pnas.71.5.1648. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Richards F. M., Knowles J. R. Glutaraldehyde as a protein cross-linkage reagent. J Mol Biol. 1968 Oct 14;37(1):231–233. doi: 10.1016/0022-2836(68)90086-7. [DOI] [PubMed] [Google Scholar]
  42. Robertson E. A., Schultz R. L. The impurities in commercial glutaraldehyde and their effect on the fixation of brain. J Ultrastruct Res. 1970 Feb;30(3):275–287. doi: 10.1016/s0022-5320(70)80063-6. [DOI] [PubMed] [Google Scholar]
  43. Round J. M. Plasma calcium, magnesium, phosphorus, and alkaline phosphatase levels in normal British schoolchildren. Br Med J. 1973 Jul 21;3(5872):137–140. doi: 10.1136/bmj.3.5872.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Sanders S. P., Levy R. J., Freed M. D., Norwood W. I., Castaneda A. R. Use of Hancock porcine xenografts in children and adolescents. Am J Cardiol. 1980 Sep;46(3):429–438. doi: 10.1016/0002-9149(80)90012-0. [DOI] [PubMed] [Google Scholar]
  45. Schoen F. J., Collins J. J., Jr, Cohn L. H. Long-term failure rate and morphologic correlations in porcine bioprosthetic heart valves. Am J Cardiol. 1983 Mar 15;51(6):957–964. doi: 10.1016/s0002-9149(83)80173-8. [DOI] [PubMed] [Google Scholar]
  46. Spray T. L., Roberts W. C. Structural changes in porcine xenografts used as substitute cardiac valves. Gross and histologic observations in 51 glutaraldehyde-preserved Hancock valves in 41 patients. Am J Cardiol. 1977 Sep;40(3):319–330. doi: 10.1016/0002-9149(77)90153-9. [DOI] [PubMed] [Google Scholar]
  47. Stenflo J., Fernlund P., Egan W., Roepstorff P. Vitamin K dependent modifications of glutamic acid residues in prothrombin. Proc Natl Acad Sci U S A. 1974 Jul;71(7):2730–2733. doi: 10.1073/pnas.71.7.2730. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Suttie J. W., Jackson C. M. Prothrombin structure, activation, and biosynthesis. Physiol Rev. 1977 Jan;57(1):1–70. doi: 10.1152/physrev.1977.57.1.1. [DOI] [PubMed] [Google Scholar]
  49. Talbert W. M., Jr, Wright P. Acute aortic stenosis of a porcine valve heterograft apparently caused by graft rejection: case report with discussion of immune mediated host response. Tex Heart Inst J. 1982 Jun;9(2):225–229. [PMC free article] [PubMed] [Google Scholar]
  50. Tanner J. M., Whitehouse R. H. Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child. 1976 Mar;51(3):170–179. doi: 10.1136/adc.51.3.170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Urist M. R. Bone: formation by autoinduction. Science. 1965 Nov 12;150(3698):893–899. doi: 10.1126/science.150.3698.893. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES